Market Overview

UPDATE: Stifel Nicolaus Downgrades Comerica to Sell on Premium Valuation, Low ROA

Share:
Related CMA
3 Stocks That Could Benefit As Fed Considers Easier Stress Tests For Regional Banks
Comerica Shares Upgraded By Goldman, Added To 'Conviction Buy' List
Latest stress test changes bad news for TBTFs, good news for smaller players (Seeking Alpha)

Stifel Nicolaus downgraded Comerica (NYSE: CMA) from Hold to Sell.

Stifel Nicolaus commented, "The shares are trading at a 25% premium to the rest of our large cap bank coverage universe despite having one of the lowest projected ROAs. With approximately 72% of the company's earning assets tied to the short-end of the yield curve (not the long end), we believe the market is way ahead of itself in assuming just how much the company benefits from the recent rise in long-term interest rates."

Comerica closed at $35.77 on Friday.

Latest Ratings for CMA

DateFirmActionFromTo
Sep 2016Goldman SachsUpgradesNeutralBuy
Sep 2016BarclaysMaintainsUnderweight
Sep 2016CLSAMaintainsOutperform

View More Analyst Ratings for CMA
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CMA)

View Comments and Join the Discussion!